[CUE] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[CUE] Cue Biopharma, Inc.
Announcement Date
29-Dec-2023
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -22.07%
YoY- 7.06%
Quarter Report
CUE's Result
CUE's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 3,336 2,658 1,717 1,821 2,100 1,382 187 579.16%
PBT -8,660 -10,171 -12,347 -13,434 -11,005 -13,185 -13,109 -24.09%
Tax 0 0 806 807 700 564 99 -
NP -8,660 -10,171 -12,347 -13,434 -11,005 -13,185 -13,208 -24.46%
Tax Rate - - - - - - - -
Total Cost 11,996 12,829 14,064 15,255 13,105 14,567 13,395 -7.07%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin -259.59 -382.66 -719.10 -737.73 -524.05 -954.05 -7,063.10 -88.87%
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -0.17 -0.20 -0.25 -0.28 -0.24 -0.29 -0.30 -31.45%
EPS Diluted -0.17 -0.20 -0.25 -0.28 -0.24 -0.29 -0.30 -31.45%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.